general

CCMB study points to new way of tackling fungal infections

Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, have identified a promising new strategy to combat fungal infections by preventing disease-causing fungi from becoming invasive, rather than killing them outright.

Most current antifungal drugs work by destroying fungal cells. However, fungi can gradually develop resistance to these medicines, making infections increasingly difficult to treat. A team led by Sriram Varahan at CCMB studied ‘Candida albicans’, a fungus commonly found on human skin and in the body. While generally harmless, it can cause serious infections when it enters the bloodstream or internal organs.

The researchers focused on ‘morphogenesis’, in which the fungus changes from a round-cell form into long, filament-like structures, a transformation allowing the pathogen to evade the body’s immune defences and spread more effectively within tissues.

Earlier studies had shown that glycolysis, the process through which cells metabolise sugar, plays a key role in controlling this shape change. Building on these findings, the team screened a library of small molecules that target glycolysis and identified two compounds capable of blocking the transformation.

Although the fungus continued to grow, it remained in its harmless rounded form suggesting that the compounds could serve as “anti-infective” agents that reduce the fungus’ ability to cause disease without necessarily eliminating it.

The study also identified pyruvate kinase, an enzyme involved in sugar metabolism, as a crucial regulator of fungal morphogenesis. Researchers further found that one of the compounds reduced biofilm formation, a protective layer that helps fungi resist treatment. The compound also increased the effectiveness of widely used antifungal drugs such as fluconazole and amphotericin B.

In a mouse model of systemic Candida infection, treatment with the lead compound significantly improved survival rates, highlighting its potential for future therapeutic development. “Our findings suggest that fungal disease-associated behaviour can be targeted without necessarily stopping fungal growth,” said Dhrumi Shah, first author of the study. “We need further studies to evaluate the compounds effectiveness and safety but by blocking the fungus from becoming invasive, they could complement existing treatments,” said Sriram Varahan.

The findings, published in ACS Infectious Diseases, emerged from a collaboration between CSIR-CCMB and the BRIC-Translational Health Science and Technology Institute, said a press release on Tuesday.

  • ccmb
  • study
  • way
  • fungal
  • point
  • infection

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

‘She set out to buy a painting a day’: on the trail of Peggy Guggenheim’s legendary shopping spree
general

‘She set out to buy a painting a day’: on the trail of Peggy Guggenheim’s legendary shopping spree

Royal Academy, London The modernist collector once ran a gallery in London – but from this confusing exhibition, it’s hard to tell what exactly was once in there Peggy Guggenheim, art enthusiast and socialite born into a wealthy New York family, was often photographed outside her palazzo in Venice with a handbag dog and outré sunglasses. The Peggy Guggenheim Collection as we now know it, however, was nearly not in her Venice palazzo but London, evidenced by a short-lived and largely overlooked period between January 1938 and June 1939 when she ran Guggenheim Jeune in Cork Street.

Read →